Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether DCE-MRI can detect changes of active disease
in rheumatoid arthritis (RA) patients after 4, 8 and 12 weeks of etanercept.